Skip to search formSkip to main contentSkip to account menu

Boutonneuse Fever

Known as: Fevers, Boutonneuse, Boutonneuse Fevers, Mediterranean tick fever 
A febrile disease of the Mediterranean area, the Crimea, Africa, and India, caused by infection with RICKETTSIA CONORII.
National Institutes of Health

Related topics

Related topics

12 relations
In BloodMicrobiologicalNorth Asian tick feverQ Fever

Broader (3)

Tick-Borne Relapsing FeverTick-borne rickettsiosisunspecified spotted fever

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The histology of “taches noires” of boutonneuse fever and demonstration ofRickettsia conorii in them by immunofluorescence
The recent increase in the incidence of boutonneuse fever in Italy provided the opportunity to study the pathology of six “taches… 
Review
2003
Review
2003
Evaluation of Clinical Diagnosis Scores for Boutonneuse Fever
Abstract: Mediterranean spotted fever (MSF) is endemic in Tunisia. Diagnosis is confirmed retrospectively based on serology… 
2000
2000
Interleukin‐12 in Human Boutonneuse Fever Caused by Rickettsia conorii
Interleukin (IL)‐12 contributes to the resistance against a number of intracellular pathogens. We examined the potential… 
1995
1995
Demonstration of Rickettsia Conorii-Induced Coagulative and Platelet Activation in vivo in Patients with Mediterranean Spotted Fever
Summary Endothelial injury in vivo induced by Rickettsia Conorii, the etiologic agent of Mediterranean Spotted Fever (MSF) has… 
1995
1995
Comparative antigenic analysis of spotted fever group rickettsiae from Israel and other closely related organisms.
Spotted fever rickettsiosis in Israel has been considered as possibly somewhat more severe than boutonneuse fever, from which it… 
Review
1993
Review
1993
Rickettsia conorii in Greece: comparison of a microimmunofluorescence assay and western blotting for seroepidemiology.
Since 1972, there have been no reports of Mediterranean spotted fever (MSF) in Greece. In 1991, a seroepidemiologic survey was… 
1992
1992
Evaluation of ciprofloxacin and doxycycline in the treatment of mediterranean spotted fever
A comparison was made of the results obtained with ciprofloxacin (750 mg/12 h) and doxycycline (100 mg/12 h), both administered p… 
1991
1991
Evidence of activation of the protein C pathway during acute vascular damage induced by Mediterranean spotted fever.
Mediterranean spotted fever (MSF) is a rickettsiosis that induces widespread microvascular injury. To obtain quantitative… 
Review
1991
Review
1991
Antibiotic treatment of rickettsiosis, recent advances and current concepts
The author reviews the recent advances in the treatment of Mediterranean Spotted Fever and Q fever. In mediterranean spotted… 
1983
1983
[Malignant form of Mediterranean boutonneuse fever. 6 cases].
Six cases of severe Mediterranean boutonneuse fever are reported. The clinical diagnosis, based on the presence of summer fever… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)